<--- Back to Details
First PageDocument Content
Date: 2016-07-05 04:16:59

Morphochem’s Investigational New Drug (IND) application accepted by FDA – Novel antibacterial for IV treatment of CDI ready to move to Phase 2 Munich (Germany), June 22, 2016 — Morphochem, a clinical-stage pharmace

Add to Reading List

Source URL: www.morphochem.de

Download Document from Source Website

File Size: 313,15 KB

Share Document on Facebook

Similar Documents